Clinical Trial

Economic Evaluation of Mindline.sg

Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effectiveness of mindline.sg, a digital mental health platform, in improving mental health literacy, emotional wellbeing, quality of life, and economic outcomes among adults in Singapore. We will conduct a randomized controlled trial (RCT) with two phases: an initial screening and a 1-month intervention. Eligible participants, identified based on mental health symptom scores, will be randomly assigned to either an intervention group using mindline.sg or a control group receiving standard mental health information. The intervention group will receive weekly prompts to engage with key features of the platform, including psychoeducation, positive psychology tools, emotion regulation exercises, and access to digital navigation for mental health services. Participants in both groups will complete surveys at baseline, post-intervention, and two months post-intervention, measuring outcomes such as mental health symptoms, resilience, wellbeing, emotion regulation, mental health literacy, and work performance. We expect mindline.sg users to show greater improvements across mental health and quality of life indicators, increased mental health literacy, and better work productivity compared to controls. This study will provide evidence on the utility of digital mental health tools in supporting population mental wellbeing and inform future digital mental health strategies in Singapore and similar contexts.
Protocol Amendment History 4 changes
critical Trial completed 2026-06-13
notable Enrollment reduced: 300 -> 242 participants 2026-06-13
notable Primary completion pushed: 2026-03 -> 2026-05-30 2026-06-13
minor Completion pushed: 2026-03 -> 2026-05-30 2026-06-13
Trial Details
NCT Number NCT07209904
Lead Sponsor Centre for Evidence and Implementation Singapore Ltd
Collaborators: Ministry of Health, Singapore
Conditions Healthy
Enrollment 242 participants
Start Date 2025-11-20
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-12